Image of

Research Integrity: Why We Should Trust Registered Clinical Trials

Image of The interplay of professional and organizational resilience during times of disruption
05/06/2020

 

In a time when we have to rely on clinical trials for COVID-19 drugs and vaccines, a new study forthcoming in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) brings good news about the credibility of registered clinical trials.

 

The Paper: Jerome Adda, Christian Decker, Marco Ottaviani (2020), “P-hacking in clinical trials and how incentives shape the distribution of results across phases”, in Proceedings of the National Academy of Sciences of the United States of America (PNAS)



04.06.2020 Bocconi Knowledge | "Research Integrity: Why We Should Trust Registered Clinical Trials"

 

Remote video URL
Why We Can Trust Coronavirus Clinical Trials